Nerve Growth Factor–Based Peptides and Optic Nerve Protection
In a rabbit glaucoma model (pressure raised by a gel in the eye), researchers injected NGF around the eye (retrobulbar) before damage. Those rabbits...
Deep research and expert guides on maintaining your visual health.
In a rabbit glaucoma model (pressure raised by a gel in the eye), researchers injected NGF around the eye (retrobulbar) before damage. Those rabbits...
Visual field loss from conditions like glaucoma can go unnoticed. Start a free trial and screen for potential blind spots in minutes.
Cenegermin is a laboratory-made version of human nerve growth factor created as a medicine to help heal damaged nerves. It is produced with biotechnology so it behaves like the natural protein the body uses to support nerve survival and repair. Doctors use it in forms that allow the medicine to reach damaged tissue directly, and it is most often applied in eye treatments to restore health to the cornea when nerves there are impaired. By delivering the growth factor where it’s needed, cenegermin encourages nerve regrowth and helps damaged tissues recover their protective and sensory functions. This can reduce the need for more invasive procedures and improve symptoms like loss of feeling or poor wound healing. Like any treatment, it can cause side effects, commonly mild local irritation or eye discomfort when used around the eye, and it must be prescribed and monitored by a clinician. The drug matters because it translates a natural repair mechanism into a practical therapy, offering a new option for conditions that previously had limited treatments. Its development reflects advances in biotechnology that allow precise replication of human proteins for medical use. Overall, cenegermin gives people with certain nerve-related injuries a way to harness the body’s own repair signals in a targeted, medically supervised way.